NIH-funded research R01 grant

Investigating the link between gut bacteria and Alzheimer's disease risk

Official title: Microbiome and AD/ADRD Risk in SOL

Funded at University of Massachusetts Lowell · NIH-11053146 · Data updated 2026-11-12

This study is looking at how the bacteria in our gut might affect the risk of Alzheimer's and related memory issues, especially in Latino communities, to help find new ways to prevent and treat these conditions.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Massachusetts Lowell
NIH-funded
Lab location1 site (Lowell, United States)
Project startFebruary 1, 2025
Project endJanuary 31, 2030
Funding year2025
Award (this year)$856,580
NIH project number1R01AG085320-01A1
Project IDNIH-11053146 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals, particularly Latinos, who are at risk for Alzheimer's disease or related dementias.

Less likely to help

Patients who do not have any risk factors for Alzheimer's disease or related dementias may not benefit from this research.

What this research studies

This research explores how the gut microbiome, which interacts with the brain, may influence the risk of Alzheimer's disease and related dementias (AD/ADRD). By studying a diverse group of individuals over a long period, the project aims to identify specific microbial patterns associated with AD/ADRD, particularly in Latino populations who are at higher risk. The researchers will analyze various biological markers and gut microbiome profiles to understand potential connections between diabetes and AD/ADRD. This comprehensive approach could lead to new prevention and treatment strategies based on gut health.

Why it matters

Potential benefit: If successful, this research could lead to innovative strategies for preventing or treating Alzheimer's disease by targeting gut health.

How similar studies have gone: While there have been limited studies on the gut microbiome's role in Alzheimer's disease, this research aims to fill a gap, particularly focusing on Latino populations, making it a novel approach.

Where this research is happening

  • University of Massachusetts Lowell
    Lowell, United States
    Active

Researchers

  • Principal investigator: Palacios, Natalia — University of Massachusetts Lowell
  • Study coordinator: Palacios, Natalia

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.